Literature DB >> 3427869

Bovine albumin antibodies in NOD mice.

H Beppu1, W E Winter, M A Atkinson, N K Maclaren, K Fujita, H Takahashi.   

Abstract

Sera from NOD mice were studied for the presence of bovine serum albumin (BSA) antibodies using an ELISA assay. NOD mice had higher levels of BSA binding and higher frequencies of BSA antibodies than did control mice. Furthermore, diabetic NOD mice had higher BSA binding, and higher frequencies of BSA Ab than did nondiabetic NOD mice. These findings are indicative of an exaggerated immune response in NOD mice to BSA that may be associated with diabetes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3427869

Source DB:  PubMed          Journal:  Diabetes Res        ISSN: 0265-5985


  6 in total

Review 1.  Beta-casein in cow's milk: a major antigenic determinant for type 1 diabetes?

Authors:  P Pozzilli
Journal:  J Endocrinol Invest       Date:  1999 Jul-Aug       Impact factor: 4.256

2.  Genes mediating environment interactions in type 1 diabetes.

Authors:  Erik Biros; Margaret A Jordan; Alan G Baxter
Journal:  Rev Diabet Stud       Date:  2006-02-10

Review 3.  Pharmacological approaches to the prevention of autoimmune diabetes.

Authors:  W E Winter; D V House; D Schatz
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 4.  A model for the involvement of MHC class II proteins in the development of type 1 (insulin-dependent) diabetes mellitus in response to bovine serum albumin peptides.

Authors:  B H Robinson; H M Dosch; J M Martin; H K Akerblom; E Savilahti; M Knip; J Ilonen
Journal:  Diabetologia       Date:  1993-04       Impact factor: 10.122

5.  Disease-associated anti-bovine serum albumin antibodies in type 1 (insulin-dependent) diabetes mellitus are detected by particle concentration fluoroimmunoassay, and not by enzyme linked immunoassay.

Authors:  J Karjalainen; T Saukkonen; E Savilahti; H M Dosch
Journal:  Diabetologia       Date:  1992-10       Impact factor: 10.122

6.  Study design of the Trial to Reduce IDDM in the Genetically at Risk (TRIGR).

Authors: 
Journal:  Pediatr Diabetes       Date:  2007-06       Impact factor: 4.866

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.